GlassScriptPhysician profile
Rebecca L Arth
NPI 1407130172
$1,041.23
in general payments reported to CMS, 2019-2025
16 companies · $157 in 2025
The $157 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $300 · 2022: $217 · 2023: $208 · 2024: $160 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $166.37 | 2021-2022 | |
| Organon LLC | $126.09 | 2022-2025 | Nexplanon |
| Agile Therapeutics, INC. | $110.02 | 2021-2023 | Twirla |
| Novo Nordisk INC | $109.29 | 2023-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $86.57 | 2021-2025 | |
| Hologic Sales and Service, LLC | $75.96 | 2021-2024 | Aptima, Thinprep 2000 Processor, Third Wave |
| Astellas Pharma US INC | $60.62 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $54.69 | 2021 | |
| Biogen, INC. | $45.04 | 2024 | |
| Exeltis, USA INC. | $44.81 | 2022-2025 | Slynd |
| Mayne Pharma Commercial LLC | $44.12 | 2023-2025 | |
| Pfizer INC. | $33.04 | 2024-2025 | |
| Therapeuticsmd, INC. | $26.82 | 2022 | |
| Mylan Pharmaceuticals INC. | $22.10 | 2021 | |
| Myovant Sciences INC. | $18.50 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Arth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.